Gentech Helps "Made in Wuhan" COVID-19 Inactivated Vaccine to Go on the Market
On February 25, the State Drug Administration approved the conditional marketing of COVID-19 inactivated vaccine of Wuhan Institute of Biological Products after Sinopharm China Biotech Beijing Institute of Biological Products was approved for conditional marketing last year. This is the second COVID-19 vaccine approved for conditional marketing in China. Shanghai Zhengfan Science and Technology Co., Ltd. ("Zhengfan Science and Technology") provided high standard and strict pharmaceutical water equipment for the research and development process of Wuhan Biological Products Research Institute, and contributed to the research, development and listing of COVID-19 vaccine.
On April 12, 2020, the the fourth day of the opening day of Wuhan, Zhengfan Technology won the bid for the COVID-19 vaccine project of Wusheng Institute, and was honored to provide a complete set of pharmaceutical water equipment for China's first COVID-19 vaccine project that entered the clinical stage. It usually takes 2-3 years for human vaccines to be officially launched from clinical use, while it only takes 10 months for the COVID-19 vaccine of Wusheng Institute. Zhengfan Technology provides Wusheng with services including system planning and design, system construction, GMP verification, and operation, covering equipment manufacturing, system installation and commissioning, and GEP project management, to meet the stringent requirements of biopharmaceutical customers for ultra-high water quality, high stability, and compliance. In addition, Zhengfan Technology can also provide overall upstream and downstream core process solutions for biopharmaceutical customers such as vaccines, monoclonal antibodies, proteins, and blood products.
"Let's cheer for Wusheng Institute and pay tribute to the heroic Wuhan!" At present, the COVID-19 Institute of Biological Products has built a biosafety workshop for inactivated vaccines and put it into large-scale production. Zhengfan Technology will work diligently with Wuhan Institute of Biological Products to strive for the development of China's high-tech industry and the realization of the national ideal of technological prosperity.
